Most just lately, it's been identified that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to a big selection of endogenous opioids. Compared with most opioid receptors, this receptor acts as a scavenger https://fane566any1.blogdanica.com/profile